Abstract
The uveal tract is the highly vascularised middle layer of the eye and consists of the iris, ciliary body and the choroid. It provides several essential functions to the eye, including nutritive supply to almost all intraocular structures, production of aqueous humor, secretion of hyaluronic acid into the vitreous and control of accommodation. It contains scattered lymphocytes between the normal choroidal pigmented melanocytes; it does not contain lymphatic vessels. Congenital abnormalities of the uvea include albinism, colobomas, corectopias, cysts as well as involvement in syndromes, e.g. neurofibromatosis. The uvea can be involved in inflammatory processes of varying degrees of severity, and they can be localised (diffuse or nodular) as well as part of systemic conditions. Trauma to the uveal tract can be either surgical or nonsurgical. Most cases show intraocular haemorrhage and loss or incarceration of intraocular structures. A particular peculiar but sight threatening condition of the uvea is sympathetic uveitis (ophthalmia), which is a severe bilateral granulomatous inflammation of the uveal tract that follows unilateral trauma or surgery. Degenerative conditions of the uvea include muscle atrophy, hyalinisation, cystic formation as well as choroidal vascularisation; the latter playing a major role in the pathogenesis of age-related macular degeneration. The tumours arising in the uvea are numerous and range from hyperplastic proliferations, to benign neoplasms, to malignancies that are rarely metastatic but typically infiltrative, to other malignancies that can be fatal in close to 50 % of patients and finally to metastatic lesions of systemic tumours within the eye.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Russell-Eggitt I. Albinism. Ophthalmol Clin North Am. 2001;14(3):533–46.
King RA, Pietsch J, Fryer JP, et al. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet. 2003;113(6):502–13.
Ragge NK, Subak-Sharpe ID, Collin JR. A practical guide to the management of anophthalmia and microphthalmia. Eye (Lond). 2007;21(10):1290–300.
Shah SP, Taylor AE, Sowden JC, et al. Anophthalmos, microphthalmos, and Coloboma in the United Kingdom: clinical features, results of investigations, and early management. Ophthalmology. 2012;119(2):362–8.
Glaser T, Walton DS, Maas RL. Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nat Genet. 1992;2(3):232–9.
Davis A, Cowell JK. Mutations in the PAX6 gene in patients with hereditary aniridia. Hum Mol Genet. 1993;2(12):2093–7.
Warburg M, Mikkelsen M, Andersen SR, et al. Aniridia and interstitial deletion of the short arm of chromosome 11. Metab Pediatr Ophthalmol. 1980;4(2):97–102.
Mataftsi A, Islam L, Kelberman D, Sowden JC, Nischal KK. Chromosome abnormalities and the genetics of congenital corneal opacification. Mol Vis. 2011;17:1624–40.
Nischal KK. A new approach to the classification of neonatal corneal opacities. Curr Opin Ophthalmol. 2012;23(5):344–54.
Kreusel KM. Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications. Fam Cancer. 2005;4(1):43–7.
Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981;88(4):348–54.
Capo H, Palmer E, Nicholson DH. Congenital cysts of the iris stroma. Am J Ophthalmol. 1993;116(2):228–32.
Kim BH, Henderson BA. Intraocular choristoma. Semin Ophthalmol. 2005;20(4):223–9.
de Smet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30(6):452–70.
Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–9.
Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005;20(3):183–90.
Kacmaz RO, Kempen JH, Newcomb C, et al. Ocular inflammation in Behcet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146(6):828–36.
Mesquida M, Molins B, Llorenc V, et al. Current and future treatments for Behcet’s uveitis: road to remission. Int Ophthalmol. 2014;34(2):365–81.
Schuler A, Coupland SE, Krause L, Bornfeld N. Malignant and non-malignant uveitis-masquerade syndromes in childhood. Klin Monbl Augenheilkd. 2007;224(6):477–82.
DeBarge LR, Chan CC, Greenberg SC, McLean IW, Yannuzzi LA, Nussenblatt RB. Chorioretinal, iris, and ciliary body infiltration by juvenile xanthogranuloma masquerading as uveitis. Surv Ophthalmol. 1994;39(1):65–71.
Thanos A, Vavvas D, Young LH, Foster CS. Choroidal neovascular membrane formation and retinochoroidopathy in a patient with systemic langerhans cell histiocytosis: a case report and review of the literature. Case Rep Ophthalmol. 2012;3(1):128–35.
Tsai JH, Galaydh F, Ching SS. Anterior uveitis and iris nodules that are associated with Langerhans cell histiocytosis. Am J Ophthalmol. 2005;140(6): 1143–5.
Rao AA, Naheedy JH, Chen JY, Robbins SL, Ramkumar HL. A clinical update and radiologic review of pediatric orbital and ocular tumors. J Oncol. 2013;2013:975908.
Damico FM, Kiss S, Young LH. Sympathetic ophthalmia. Semin Ophthalmol. 2005;20(3):191–7.
Chu XK, Chan CC. Sympathetic ophthalmia: to the twenty-first century and beyond. J Ophthal Inflamm Infect. 2013;3(1):49.
Griepentrog GJ, Lucarelli MJ, Albert DM, Nork TM. Sympathetic ophthalmia following evisceration: a rare case. Ophthal Plast Reconstr Surg. 2005;21(4):316–8.
Brour J, Desjardins L, Lehoang P, et al. Sympathetic ophthalmia after proton beam irradiation for choroidal melanoma. Ocul Immunol Inflamm. 2012;20(4):273–6.
Damato B. Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture. Eye (Lond). 2012;26(9):1157–72.
Bonaccolto G. Congenital coloboma associated with cystic degeneration of the ciliary body. AMA Arch Ophthalmol. 1957;57(1):18.
Mannino G, Malagola R, Abdolrahimzadeh S, Villani GM, Recupero SM. Ultrasound biomicroscopy of the peripheral retina and the ciliary body in degenerative retinoschisis associated with pars plana cysts. Br J Ophthalmol. 2001;85(8):976–82.
Ambati J. Age-related macular degeneration and the other double helix. The Cogan Lecture. Invest Ophthalmol Vis Sci. 2011;52(5):2165–9.
Liu MM, Chan CC, Tuo J. Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics. 2012;6:13.
Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13(6):438–51.
Ferris 3rd FL, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120(4):844–51.
Singh AD, Damato B, Howard P, Harbour JW. Uveal melanoma: genetic aspects. Ophthalmol Clin North Am. 2005;18(1):85–97, viii.
Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005;112(10):1784–9.
Kivela T, Eskelin S. Transformation of nevus to melanoma. Ophthalmology. 2006;113(5):887–8.e881.
Reidy JJ, Apple DJ, Steinmetz RL, et al. Melanocytoma: nomenclature, pathogenesis, natural history and treatment. Surv Ophthalmol. 1985;29(5):319–27.
Esmaili DD, Mukai S, Jakobiec FA, Kim IK, Gragoudas ES. Ocular melanocytoma. Int Ophthalmol Clin. 2009;49(1):165–75.
Fineman MS, Eagle Jr RC, Shields JA, Shields CL, De Potter P. Melanocytomalytic glaucoma in eyes with necrotic iris melanocytoma. Ophthalmology. 1998;105(3):492–6.
Mudhar HS, Doherty R, Salawu A, Sisley K, Rennie IG. Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations. Br J Ophthalmol. 2013;97(7):924–8.
Apple DJ, Craythorn JM, Reidy JJ, Steinmetz RL, Brady SE, Bohart WA. Malignant transformation of an optic nerve melanocytoma. Can J Ophthalmol. 1984;19(7):320–5.
Barr CC, Zimmerman LE, Curtin VT, Font RL. Bilateral diffuse melanocytic uveal tumors associated with systemic malignant neoplasms. A recently recognized syndrome. Arch Ophthalmol. 1982;100(2):249–55.
Pulido JS, Flotte TJ, Raja H, et al. Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation. Eye (Lond). 2013;27:1058–62.
Bechrakis NE, Haas G, Blatsios G. Intraocular manifestations of systemic neoplasms. Klin Monbl Augenheilkd. 2011;228(7):586–592.
Chahud F, Young RH, Remulla JF, Khadem JJ, Dryja TP. Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers: review of a process particularly associated with gynecologic cancers. Am J Surg Pathol. 2001;25(2):212–8.
Mudhar HS, Scott I, Ul-Hassan A, et al. Bilateral diffuse uveal melanocytic hyperplasia: molecular characterization and novel association with bilateral renal papillary carcinoma. Histopathology. 2012;61(4):751–4.
Carbone M, Ferris LK, Baumann F, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012;10:179.
Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153–9.
McLean IW, Zimmerman LE, Evans RM. Reappraisal of Callender’s spindle a type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol. 1978;86(4):557–64.
Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114(10):1925–31.
Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115(10):1778–85.
Angi M, Damato B, Kalirai H, Dodson A, Taktak A, Coupland SE. Immunohistochemical assessment of mitotic count in uveal melanoma. Acta Ophthalmol. 2011;89(2):e155–60.
Coupland SE, Vorum H, Mandal N, et al. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Invest Ophthalmol Vis Sci. 2009;51(1):12–20.
Coupland SE, Lake SL, Zeschnigk M, Damato B. Molecular pathology of uveal melanoma. Eye (Lond). 2013;27(2):230–42.
Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457(7229):599–602.
Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010;363(23):2191–9.
Damato B, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res. 2010;16(24):6083–92.
Damato B, Eleuteri A, Taktak AF, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30(5):285–95.
Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205–9.
Onken MD, Worley LA, Char DH, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology. 2012;119(8):1596–603.
Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330(6009):1410–3.
Singh AD, Kaiser PK, Sears JE. Choroidal hemangioma. Ophthalmol Clin North Am. 2005;18(1):151–61, ix.
Heimann H, Damato B. Congenital vascular malformations of the retina and choroid. Eye (Lond). 2010;24(3):459–67.
Heimann H, Jmor F, Damato B. Imaging of retinal and choroidal vascular tumours. Eye (Lond). 2013;27(2):208–16.
Shields CL, Shields JA, Augsburger JJ. Choroidal osteoma. Surv Ophthalmol. 1988;33(1):17–27.
Saavedra E, Singh AD, Sears JE, Ratliff NB. Plexiform pigmented schwannoma of the uvea. Surv Ophthalmol. 2006;51(2):162–8.
Lee SH, Hong JS, Choi JH, Chung WS. Choroidal schwannoma. Acta Ophthalmol Scand. 2005;83(6):754–6.
Venturini G, Moulin AP, Deprez M, et al. Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome. Ophthalmology. 2012;119(4):857–64.
You JY, Finger PT, Iacob C, McCormick SA, Milman T. Intraocular schwannoma. Surv Ophthalmol. 2013;58(1):77–85.
Vannas S, Raitta C, Tarkkanen A. Neurilemmoma of the choroid in Recklinghausen’s disease. Acta Ophthalmol Suppl. 1974;123:126–33.
Freedman SF, Elner VM, Donev I, Gunta R, Albert DM. Intraocular neurilemmoma arising from the posterior ciliary nerve in neurofibromatosis. Pathologic findings. Ophthalmology. 1988;95(11):1559–64.
Donovan BF. Neurilemoma of the ciliary body. AMA Arch Ophthalmol. 1956;55(5):672–5.
Kuchle M, Holbach L, Schlotzer-Schrehardt U, Naumann GO. Schwannoma of the ciliary body treated by block excision. Br J Ophthalmol. 1994;78(5):397–400.
Thaller VT, Perinti A, Perinti A. Benign schwannoma simulating a ciliary body melanoma. Eye (Lond). 1998;12(Pt 1):158–9.
Kim IT, Chang SD. Ciliary body schwannoma. Acta Ophthalmol Scand. 1999;77(4):462–6.
Hufnagel TJ, Sears ML, Shapiro M, Kim JH. Ciliary body neurilemoma recurring after 15 years. Graefes Arch Clin Exp Ophthalmol. 1988;226(5):443–6.
Laverone F. On a case of solitary neurinoma of the iris. Ann Ottalmol Clin Ocul. 1967;93(11):1210–8.
Racz M, Szabo J. Two cases of neurilemmoma of the anterior uvea (author’s transl). Klin Monbl Augenheilkd. 1973;163(5):605–9.
Brewitt H, Huerkamp B, Richter K. Choroid neurilemmoma. Considerations for clinical differential diagnostics. Klin Monbl Augenheilkd. 1976;169(6):750–4.
Xian J, Xu X, Wang Z, et al. MR imaging findings of the uveal schwannoma. AJNR Am J Neuroradiol. 2009;30(4):769–73.
Matsuo T, Notohara K. Choroidal schwannoma: immunohistochemical and electron-microscopic study. Ophthalmologica. 2000;214(2):156–60.
Turell ME, Hayden BC, McMahon JT, Schoenfield LR, Singh AD. Uveal schwannoma surgery. Ophthalmology. 2009;116(1):163, e166.
Cho YJ, Won JB, Byeon SH, et al. A choroidal schwannoma confirmed by surgical excision. Korean J Ophthalmol. 2009;23(1):49–52.
Packard RB, Harry J. Choroidal neurilemmoma–an unusual clinical misdiagnosis. Br J Ophthalmol. 1981;65(3):189–91.
Shields JA, Font RL, Eagle Jr RC, Shields CL, Gass JD. Melanotic schwannoma of the choroid. Immunohistochemistry and electron microscopic observations. Ophthalmology. 1994;101(5):843–9.
Shields JA, Sanborn GE, Kurz GH, Augsburger JJ. Benign peripheral nerve tumor of the choroid: a clinicopathologic correlation and review of the literature. Ophthalmology. 1981;88(12):1322–9.
Huang Y, Wei W. Choroidal schwannoma presenting as nonpigmented intraocular mass. J Clin Oncol. 2012;30(31):e315–7.
Vautrin R, Mertens P, Streichenberger N, Ceruse P, Truy E. Oto-neuro-surgical approach and accessibility to the cochlear nuclei. Significance in auditory brain stem implant. Rev Laryngol Otol Rhinol (Bord). 1998;119(3):171–6.
Shields JA, Hamada A, Shields CL, De Potter P, Eagle Jr RC. Ciliochoroidal nerve sheath tumor simulating a malignant melanoma. Retina. 1997;17(5):459–60.
Goto H, Mori H, Shirato S, Usui M. Ciliary body schwannoma successfully treated by local resection. Jpn J Ophthalmol. 2006;50(6):543–6.
Smith PA, Damato BE, Ko MK, Lyness RW. Anterior uveal neurilemmoma–a rare neoplasm simulating malignant melanoma. Br J Ophthalmol. 1987;71(1):34–40.
Kiratli H, Ustunel S, Balci S, Soylemezoglu F. Ipsilateral ciliary body schwannoma and ciliary body melanoma in a child. J AAPOS. 2010;14(2):175–7.
Pineda 2nd R, Urban Jr RC, Bellows AR, Jakobiec FA. Ciliary body neurilemoma. Unusual clinical findings intimating the diagnosis. Ophthalmology. 1995;102(6):918–23.
Rosso R, Colombo R, Ricevuti G. Neurilemmoma of the ciliary body: report of a case. Br J Ophthalmol. 1983;67(9):585–7.
Carracedo A, Alimonti A, Pandolfi PP. PTEN level in tumor suppression: how much is too little? Cancer Res. 2011;71(3):629–33.
Shields JA, Shields CL, Eagle Jr RC, De Potter P. Observations on seven cases of intraocular leiomyoma. The 1993 Byron Demorest Lecture. Arch Ophthalmol. 1994;112(4):521–8.
Koletsa T, Karayannopoulou G, Dereklis D, Vasileiadis I, Papadimitriou CS, Hytiroglou P. Mesectodermal leiomyoma of the ciliary body: report of a case and review of the literature. Pathol Res Pract. 2009;205(2):125–30.
Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM. Re-evaluation of “reactive lymphoid hyperplasia of the uvea”: an immunohistochemical and molecular analysis of 10 cases. Ophthalmology. 2000;107(1):151–8.
Coupland SE, Foss HD, Hidayat AA, Cockerham GC, Hummel M, Stein H. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. J Pathol. 2002;197(3):333–40.
Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Experiment Ophthalmol. 2008;36(6):564–78.
Coupland SE, Joussen A, Anastassiou G, Stein H. Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report. Graefes Arch Clin Exp Ophthalmol. 2005;243(5):482–6.
Fuller ML, Sweetenham J, Schoenfield L, Singh AD. Uveal lymphoma: a variant of ocular adnexal lymphoma. Leuk Lymphoma. 2008;49(12):2393–7.
Mudhar HS, Sethuraman C, Khan MD, Jan SU. Intracular, pan-uveal intravascular large B-cell lymphoma associated with choroidal infarction and choroidal tri-lineage extramedullary haemtopoiesis. Histopathology. 2007;51(2):275–9.
Coutinho AB, Muccioli C, Martins MC, Belfort Jr R, Sant’Anna AE, Burnier Jr MN. Extranodal B-cell lymphoma of the uvea: a case report. Can J Ophthalmol. 2005;40(5):623–6.
Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004;242(11):901–13.
Jensen OA, Johansen S, Kiss K. Intraocular T-cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Report of a case and survey of the literature. Graefes Arch Clin Exp Ophthalmol. 1994;232(3):148–52.
Lobo A, Larkin G, Clark BJ, Towler HM, Lightman S. Pseudo-hypopyon as the presenting feature in B-cell and T-cell intraocular lymphoma. Clin Experiment Ophthalmol. 2003;31(2):155–8.
Sarraf D, Jain A, Dubovy S, Kreiger A, Fong D, Paschal J. Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Retina. 2005;25(1):94–8.
Garcia-Alvarez C, Saornil MA, Blanco G, Mendez MC, Lopez-Lara F. Extranodal B-cell uveal lymphoma with extraocular involvement. Can J Ophthalmol. 2009;44(2):213–4.
Gaucher D, Bodaghi B, Charlotte F, et al. MALT-type B-cell lymphoma masquerading as scleritis or posterior uveitis. J Fr Ophtalmol. 2005;28(1):31–8.
Ahmed M, Androudi S, Brazitikos P, Paredes I, Foster CS. 360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol. 2004;19(3–4):127–9.
Mashayekhi A, Shields CL, Shields JA. Iris involvement by lymphoma: a review of 13 cases. Clin Experiment Ophthalmol. 2013;41(1):19–26.
Yahalom C, Cohen Y, Averbukh E, Anteby I, Amir G, Pe’er J. Bilateral iridociliary T-cell lymphoma. Arch Ophthalmol. 2002;120(2):204–7.
Yamada K, Hirata A, Kimura A, Tanihara H. A case of primary B-cell type non-Hodgkin lymphoma originating in the iris. Am J Ophthalmol. 2003;136(2):380–2.
Jakobiec FA, Sacks E, Kronish JW, Weiss T, Smith M. Multifocal static creamy choroidal infiltrates. An early sign of lymphoid neoplasia. Ophthalmology. 1987;94(4):397–406.
Kase S, Saito W, Saito A, Ohno S. Uveal effusion syndrome caused by choroidal invasion of malignant lymphoma. Jpn J Ophthalmol. 2010;54(1):109–10.
Mathai A, Lall A, Jain R, Pathengay A. Systemic non-Hodgkin’s lymphoma masquerading as Vogt-Koyanagi-Harada disease in an HIV-positive patient. Clin Experiment Ophthalmol. 2006;34(3):280–2.
Grossniklaus HE, Martin DF, Avery R, et al. Uveal lymphoid infiltration. Report of four cases and clinicopathologic review. Ophthalmology. 1998;105(7):1265–73.
Verity DH, Graham EM, Carr R, van der Walt JD, Stanford MR. Hypopyon uveitis and iris nodules in non-Hodgkin’s lymphoma: ocular relapse during systemic remission. Clin Oncol (R Coll Radiol). 2000;12(5):292–4.
Berthold S, Kottler UB, Frisch L, Radner H, Pfeiffer N. Secondary glaucoma in hyphema, hypopyon, iris prominence and iris hyperemia. Ophthalmologe. 2005;102(3):290–2.
Saga T, Ohno S, Matsuda H, Ogasawara M, Kikuchi K. Ocular involvement by a peripheral T-cell lymphoma. Arch Ophthalmol. 1984;102(3):399–402.
Yoo JH, Kim SY, Jung KB, Lee JJ, Lee SJ. Intraocular involvement of a nasal natural killer T-cell lymphoma: a case report. Korean J Ophthalmol. 2012;26(1):54–7.
Milman T, Petousis V, McCormick SA, Finger PT. Anterior segment tumor aspiration cutter-assisted biopsy: experience with pathology. Am J Ophthalmol. 2011;152(5):776–83, e771.
Economou MA, Kopp ED, All-Ericsson C, Seregard S. Mantle cell lymphoma of the iris. Acta Ophthalmol Scand. 2007;85(3):341–3.
Ralli M, Goldman JW, Lee E, Pinter-Brown LC, Glasgow BJ, Sarraf D. Intraocular involvement of mycosis fungoides. Arch Ophthalmol. 2009;127(3):343–5.
Shimonagano Y, Nakao K, Sakamoto T, Uozumi K, Haraguchi K. Iris involvement in natural killer/T-cell lymphoma. Jpn J Ophthalmol. 2006;50(6):557–8.
Goldey SH, Stern GA, Oblon DJ, Mendenhall NP, Smith LJ, Duque RE. Immunophenotypic characterization of an unusual T-cell lymphoma presenting as anterior uveitis. A clinicopathologic case report. Arch Ophthalmol. 1989;107(9):1349–53.
Tavallali A, Shields CL, Bianciotto C, Shields JA. Choroidal lymphoma masquerading as anterior ischemic optic neuropathy. Eur J Ophthalmol. 2010;20(5):959–62.
Ponzoni M, Ferreri AJ, Guidoboni M, et al. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin Cancer Res. 2008;14(18):5794–800.
Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96(8):586–94.
Ferreri AJ, Dolcetti R, Magnino S, Doglioni C, Ponzoni M. Chlamydial infection: the link with ocular adnexal lymphomas. Nat Rev Clin Oncol. 2009;6(11):658–69.
Chanudet E, Zhou Y, Bacon CM, et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol. 2006;209(3):344–51.
Duker JS, Shields JA, Ross M. Intraocular large cell lymphoma presenting as massive thickening of the uveal tract. Retina. 1987;7(1):41–5.
Fredrick DR, Char DH, Ljung BM, Brinton DA. Solitary intraocular lymphoma as an initial presentation of widespread disease. Arch Ophthalmol. 1989;107(3):395–7.
Parikh AH, Khan SH, Wright Jr JD, Oh KT. Systemic non-Hodgkin’s lymphoma simulating primary intraocular lymphoma. Am J Ophthalmol. 2005;139(3):573–4.
Knapp AJ, Gartner S, Henkind P. Multiple myeloma and its ocular manifestations. Surv Ophthalmol. 1987;31(5):343–51.
Orellana J, Friedman AH. Ocular manifestations of multiple myeloma, Waldenstrom’s macroglobulinemia and benign monoclonal gammopathy. Surv Ophthalmol. 1981;26(3):157–69.
Honavar SG, Shields JA, Shields CL, Demirci H, Ehya H. Extramedullary plasmacytoma confined to the choroid. Am J Ophthalmol. 2001;131(2):277–8.
Pilon AF, Rhee PS, Messner LV. Bilateral, persistent serous macular detachments with Waldenstrom’s macroglobulinemia. Optom Vis Sci. 2005;82(7):573–8.
Ahn ES, Singh AD, Smith SD. Mantle cell lymphoma with uveal metastasis. Leuk Lymphoma. 2010;51(7):1354–5.
Leonardy NJ, Rupani M, Dent G, Klintworth GK. Analysis of 135 autopsy eyes for ocular involvement in leukemia. Am J Ophthalmol. 1990;109(4):436–44.
Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control. 2008;19(4):379–90.
Buchan J, McKibbin M, Burton T. The prevalence of ocular disease in chronic lymphocytic leukaemia. Eye (Lond). 2003;17(1):27–30.
Robb RM, Ervin LD, Sallan SE. A pathological study of eye involvement in acute leukemia of childhood. Trans Am Ophthalmol Soc. 1978;76:90–101.
Kincaid MC, Green WR. Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983;27(4):211–32.
Schachat AP, Markowitz JA, Guyer DR, Burke PJ, Karp JE, Graham ML. Ophthalmic manifestations of leukemia. Arch Ophthalmol. 1989;107(5):697–700.
Rosenthal AR. Ocular manifestations of leukemia. A review. Ophthalmology. 1983;90(8):899–905.
Riss JM, Kaplanski G, Righini-Chossegros M, Harle JR, Escoffier P, Saracco JB. Bilateral serous detachment of neuroepithelium of the posterior pole disclosing acute leukemia. J Fr Ophtalmol. 1990;13(11–12):563–8.
Stewart MW, Gitter KA, Cohen G. Acute leukemia presenting as a unilateral exudative retinal detachment. Retina. 1989;9(2):110–4.
Tang RA, Vila-Coro AA, Wall S, Frankel LS. Case report. Acute leukemia presenting as a retinal pigment epithelium detachment. Arch Ophthalmol. 1988;106(1):21–2.
Abdallah E, Hajji Z, Mellal Z, Belmekki M, Bencherifa F, Berraho A. Macular serous detachment revealing acute lymphoblastic leukemia. J Fr Ophtalmol. 2005;28(1):39–44.
Thill M, Schwartz R, Fiedler W, Linke S. Bilateral retinal pigment epithelial detachment as the presenting symptom of acute myeloid leukaemia. Eye (Lond). 2006;20(7):851–2.
Malik R, Shah A, Greaney MJ, Dick AD. Bilateral serous macular detachment as a presenting feature of acute lymphoblastic leukemia. Eur J Ophthalmol. 2005;15(2):284–6.
Fackler TK, Bearelly S, Odom T, Fekrat S, Cooney MJ. Acute lymphoblastic leukemia presenting as bilateral serous macular detachments. Retina. 2006;26(6):710–2.
Moulin AP, Bucher M, Pournaras JA, Nguyen C, Ambresin A. Fluorescein and indocyanine green angiography findings in B cell lymphoblastic leukemia mimicking acute central serous chorioretinopathy. Klin Monbl Augenheilkd. 2010;227(4):342–4.
Zimmerman LE, Thoreson HT. Sudden Loss of Vision in Acute Leukemia. A clinicopathologic report of two unusual cases. Surv Ophthalmol. 1964;9:467–73.
Johnston SS, Ware CF. Iris involvement in leukaemia. Br J Ophthalmol. 1973;57(5):320–4.
Arbuthnot CD, Bradbury M, Darbyshire PJ. Relapsing acute myeloid leukaemia manifesting as uveitis with hypopyon. Br J Haematol. 2007;136(4):520.
Abramson DH, Wachtel A, Watson CW, Jereb B, Wollner N. Leukemic hypopyon. J Pediatr Ophthalmol Strabismus. 1981;18(3):42–4.
Buggage RR, Myers-Powell B, McManaway 3rd J, Shen D, Robinson MR, Chan CC. Detection of the Philadelphia chromosome in the iris of a child with acute lymphoblastic leukaemia. Histopathology. 2005;46(3):350–2.
Schachat AP, Jabs DA, Graham ML, Ambinder RF, Green WR, Saral R. Leukemic iris infiltration. J Pediatr Ophthalmol Strabismus. 1988;25(3):135–8.
Martin B. Infiltration of the iris in chronic lymphatic leukaemia. Br J Ophthalmol. 1968;52(10):781–5.
Blodi FC. The difficult diagnosis of choroidal melanoma. Arch Ophthalmol. 1963;69:253–6.
Brightbill F. An unusual case of central serous retinopathy. Invest Ophthalmol Vis Sci. 1971;10(60):467.
Clayman HM, Flynn JT, Koch K, Israel C. Retinal pigment epithelial abnormalities in leukemic disease. Am J Ophthalmol. 1972;74(3):416–9.
Kelly LM, Gilliland DG. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet. 2002;3:179–98.
Teitell MA, Pandolfi PP. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol. 2009;4: 175–98.
Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104(8):1265–76.
Kreusel KM, Bechrakis N, Wiegel T, Emmerlich T, Foerster MH. Clinical characteristics of choroidal metastasis. Ophthalmologe. 2003;100(8):618–22.
Anderson MF, Coupland SE, Bissett D, Atta H, Damato BE. Choroidal metastasis from primary pulmonary leiomyosarcoma. Clin Experiment Ophthalmol. 2011;39(7):705–7.
Shields JA, Eagle Jr RC, Shields CL, De Potter P. Acquired neoplasms of the nonpigmented ciliary epithelium (adenoma and adenocarcinoma). Ophthalmology. 1996;103(12):2007–16.
Buettner H. Congenital hypertrophy of the retinal pigment epithelium. Am J Ophthalmol. 1975;79(2): 177–89.
Trichopoulos N, Augsburger JJ, Schneider S. Adenocarcinoma arising from congenital hypertrophy of the retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 2006;244(1):125–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Coupland, S.E., Moulin, A. (2015). The Uvea. In: Heegaard, S., Grossniklaus, H. (eds) Eye Pathology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43382-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-43382-9_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43381-2
Online ISBN: 978-3-662-43382-9
eBook Packages: MedicineMedicine (R0)